Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alpha Tau Medical Ltd. - Ordinary Shares
(NQ:
DRTS
)
2.320
+0.020 (+0.87%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpha Tau Medical Ltd. - Ordinary Shares
< Previous
1
2
3
Next >
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
October 21, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Treats First Patient with Recurrent Lung Cancer
October 10, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024
-Trial to focus on particularly vulnerable subset of patients, following strong clinician interest in use of the Alpha DaRT in this patient population -
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Expert Ratings for Alpha Tau Medical
December 15, 2023
Via
Benzinga
Analyst Ratings for Alpha Tau Medical
November 17, 2023
Via
Benzinga
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
August 14, 2024
DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
June 25, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024
May 20, 2024
DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
May 13, 2024
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Recap: Alpha Tau Medical Q1 Earnings
May 23, 2023
Via
Benzinga
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023
March 07, 2024
DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via
Benzinga
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
November 28, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
November 20, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
October 30, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 25, 2023
Via
Benzinga
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
October 24, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
September 14, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
August 29, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 18, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 18, 2023
We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
August 17, 2023
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 25, 2023
Via
Benzinga
Sidoti Events, LLC's Virtual June Small-Cap Conference
June 13, 2023
Via
ACCESSWIRE
Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
May 17, 2023
-First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of new and recurrent squamous cell carcinoma of the...
From
Alpha Tau Medical Ltd.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
